New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor

Molecular Nutrition and Food Research

Volumn 51, Issue 9, 2007, Pages 1131-1146

  Pfohl Leszkowicz, Annie ^a,f   Tozlovanu, Mariana ^a   Manderville, Richard ^b   Peraica, Maja ^c   Castegnaro, Marcel ^a,d   Stefanovic, Vladislav ^e  

^a Ecole Nationale Superieure d'Architecture de Toulouse   (France)

^b UNIVERSITY OF GUELPH   (Canada)

^c INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^d Faculty of Medicine ^*

^e University Clinical Center Faculty of Medicine   (Serbia)

^f LABORATOIRE DE GÉNIE CHIMIQUE   (France)

Author keywords

Aristolochic acid; BEN; Ochratoxin A; Slimming regimen; Urinary tract tumor

Indexed keywords

ANTIOBESITY AGENT; ARISTOLOCHIC ACID; ARISTOLOCHIC ACID I; CITRININ; MYCOTOXIN; OCHRATOXIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BELGIUM; BULGARIA; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CROATIA; DNA ADDUCT; DRUG EFFECT; FEMALE; FOOD ANALYSIS; FRANCE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; URINARY TRACT CANCER; URINE; YUGOSLAVIA;

AGED; AGED, 80 AND OVER; ANTI-OBESITY AGENTS; ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; BELGIUM; BULGARIA; CELL LINE; CELL SURVIVAL; CITRININ; CROATIA; DNA ADDUCTS; FEMALE; FOOD ANALYSIS; FRANCE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MYCOTOXINS; OCHRATOXINS; UROLOGIC NEOPLASMS; YUGOSLAVIA;

EID: 34948903292     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700045     Document Type: Article

References (56)

1. Chernozemsky, I. N., Stoyanov, I. S., Petkova-Bocharova, T. K., Nikolov, I. G. et al., Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district Bulgaria, Int. J. Cancer 1977, 19, 1-11.
2. Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I. N., Castegnaro, M., Balkan endemic nephropathy and the associated urinary tract tumors: Review on etiological causes, potential role of mycotoxins, Food Addit. Contam. 2002, 19, 282-302.
3. Stefanovic, V., Toncheva, D., Atanasova, S., Polenakovic, M., Etiology of Balkan endemic nephropathy and associated urothelial cancer, Am. J. Nephrol. 2006, 26, 1-11.
4. Pfohl-Leszkowicz, A., Manderville, R., Review on Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans, Mol. Nutr. Food Res. 2007, 51, 61-99.
5. Akhmeteli, M. A., Epidemiology of endemic nephropathy, in: Bulgarian Academy of Sciences (Ed.), Endemic Nephropathy, Proceedings of the Second International Symposium on Endemic Nephropathy 9-12 November 1972, Sofia, Bulgaria 1972, pp. 19-23.
6. Nikolic, J., Djojic, M., Crnomarkovic, D., Marinkovic, J., Upper urothelial tumors and Balkan endemic nephropathydose responsible diseases, Facta Univ., Ser. Med. Biol. 2002, 9, 114-118.
7. Petkova-Bocharova, T., Castegnaro, M., Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria, Food Addit. Contam. 1985, 2, 267-270.
8. Petkova-Bocharova, T., Castegnaro, M., Michelon, J., Maru, V., Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria, in: Castegnaro, M. Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, IARC Sci. Publ. No. 115, Lyon, IARC, 1991. pp. 83-87.
9. Vrabcheva, T., Usleber, E., Dietrich, R., Martlbauer, E., Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy, J. Agric. Food Chem. 2000, 48, 2483-2488.
10. Abouzied, M. M., Horvath, A. D., Podlesny, P. M., Regina, N. P. et al., Ochratoxin A concentration in food and feed from a region with Balkan endemic nephropathy, Facta Univ.: Ser. Med. Biol. 2002, 9, 129.
11. Kanisawa, M., Synergistic effect of citrinin on hepatorenal carcinogenesis of ochratoxin A in mice, Dev. Food Sci. 1984, 7, 245-254.
12. Jeswal, P., Cumulative effect of ochratoxin A and citrinin on induction of hepatorenal carcinogenesis in mice (Mus musculus), Biomed. Lett. 1995, 52, 269-275.
13. Ivic, M., The problem of etiology of endemic nephropathy, Acta Fac. Med. Naissensis 1970, 1, 29-37.
14. Hranjec, T., Kovac, A., Kos, J., Mao, W., et al., Endemic nephropathy: The case for Chronic poisonning by Aristolochia, Croat. Med. J. 2005, 46, 116-125.
15. Nortier, J. L., Muniz, M. C., Schmeiser, H. H., Arlt, V. M., et al., Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia species), New Engl. J. Med. 2000, 342, 1686-1692.
16. Arlt, V M., Alunni-Perret, V., Quatrehomme, G., Ohayon, P., et al., Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer, Int. J. Cancer 2004, 111, 977-980.
17. Vanhaelen, M., Vanhaelen-Fastre, R., But, P., Vanherweghem, J.-L., Identification of aristolochic acid in Chinese herbs, Lancet 1994, 343, 174.
18. Vanherweghem, J.-L., Depierreux, M., Tielemans, C., Abramowicz, D., et al., Rapidly progressive interstitial renal fibrosis in young women - Association with slimming regimen including Chinese herbs, Lancet 1993, 341, 387-391.
19. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., Manderville, R. A., Ochratoxin A forms a carbon-bonded C8_deoxyguanosine nucleoside adduct: Implication for C8_reactivity by a phenolic radical, Chem. Res. Toxicol. 2004, 17, 1289-1296.
20. Tozlovanu, M., Faucet-Marquis, V, Pfohl-Leszkowicz, A., Manderville, R. A., Genotoxicity of the hydroquinone metabolite of ochratoxin A: Structure-activity relationships for covalent DNA adduction, Chem. Res. Toxicol. 2006, 19, 1241-1247.
21. Stengel, B., Jones, E., Insuffisance rénale terminale associée à la consommation d'herbes chinoises en France, Néphrologie 1998, 19, 15-29.
22. Pfohl-Leszkowicz, A., Castegnaro, M., Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation, Food Addit. Contam. 2005, Suppl. 1, 75-87.
23. 1. Development of a new method for simultaneous extractions of ochratoxin A and citrinin, Food Chem. 2005, 92, 391-400.
24. Castegnaro, M., Canadas, D., Vrabcheva, T., Petkova-Bocharova, T., et al., Balkan endemic nephropathy: Role of ochratoxin A through biomarkers, Mol. Nutr. Food Res. 2006, 50, 519-529.
25. Swenberg, J. A., Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies, IARC Sci. Publ. 2004, 157, 237-246.
26. Otteneder, M., Lutz, W. K., Correlation of DNA adduct levels with tumor incidence: Carcinogenic potency of DNA adducts, Mutat. Res. 1999, 424, 237-247.
27. Kyrtopoulos, S. A., Biomarkers in environmental carcinogenesis research: Striving for a new momentum, Toxicol. Lett. 2006, 162, 3-15.
28. Poirier, M. C., Santella, R. M., Weston, A., Carcinogen macromolecular adducts and their measurement, Carcinogenesis 2000, 21, 353-359.
29. Vaino, H., Use of biomarkers in risk assessment, Int. J. Hyg. Environ. Health 2001, 204, 91-102.
30. Ross, J. A., Nelson, G. B., Wilson, K. H., Rabinowitz, J. R., et al., Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time integrated DNA adduct level, Cancer Res. 1995, 55, 1039-1044.
31. Prahalad, A. K., Ross, J. A., Nelson, G. B., Roop, B. C., et al., Dibenzo[a, 1]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung, Carcinogenesis 1997, 18, 1955-1963.
32. Williams, C. S., Mann, M., Dubois, R. N., The role of cyclooxygenase in inflammation cancer and development, Oncogene 1999, 18, 7908-7916.
33. Wang, J. L., Cheng, H. F., Shappell, S., Harris, R. C., A selective cyclooxygenase 2 inhibitor decreases proteinuria and retards progressive renal injury in rats, Kidney Int. 2000, 57, 2334-2342.
34. Zha, S., Yegnasubramanian, V., Nelson, W., Isaacs, W., De Marzo, A., Cyclooxygenases in cancer: Progress and perspectives, Cancer Lett. 2004, 215, 1-20.
35. Castegnaro, M., Mohr, U, Pfohl-Leszkowicz, A., Estève, J., et al., Sex and strain-specific induction of renal tumours by ochratoxin A rats correlates with DNA adduction, Int. J. Cancer 1998, 77, 70-75.
36. Pfohl-Leszkowicz, A., Pinelli, E., Bartsch, H., Mohr, U, Castegnaro, M., Sex and strain differences in ochratoxin A metabolism and DNA adduction in two strains of rats, Mol. Carcinog. 1998, 23, 76-83.
37. Gekle, M., Sauvant, C., Schwerdt, G., Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells, Mol. Nutr. Food Res. 2005, 49, 118-130.
38. Fisher, W., Lutz, W. K., Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2′-deoxyguanosine, and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbnez[a]anthracene, Proc. Natl. Acad. Sci. USA 1995, 92, 5900-5904.
39. Wiessler, M., DNA adducts of pyrrolizidine alkaloids, nitroimidazoles and aristolochic acid, in: Hemminki, K., Dipple, A., Shuker, D. B. G., Kadulubar, F. P., et al. (Eds.), DNA Adducts: Identification and Biological Significance, IARC Sci. Publ. 1994, 125, 165-177.
40. Hemminki, K., Thilly, W. G., Implications of results of molecular epidemiology on DNA adducts, their repair and mutations for mechanisms of human cancer, IARC Sci. Publ. 2004, 157, 217-235.
41. Wild, C. P., Turner, P. C., The toxicology of aflatoxins as a basis for public health decisions, Mutagenesis 2002, 17, 471-481.
42. Kuiper-Goodman, T., Scott, P. M., Risk assessment of the mycotoxin ochratoxin A, Biomed. Environ. Sci. 1989, 2, 179-248.
43. Stoev, S. D., Stoeva, J., Anguelov, G., Hald, B., et al., Haematological, biochemical and toxicological investigations in spontaneous cases with different frequency of porcine nephropathy in Bulgaria, J. Vet. Med. 1998, 45, 229-236.
44. Pfohl-Leszkowicz, A., Vrabcheva, T., Petkova-Bocharova, T., Garren, L., et al., Analysis of ochratoxin a in serum, urine and food consumed by inhabitants from an area with Balkan endemic nephropathy: A 1 month follow up study, in: Njapau, H., Trujillio, S., Van Egmond, H. P., Park, D. L. (Eds.), Mycotoxins and Phycotoxins, Proceeding of the XIth International IUPAC Symposium on Mycotoxins and Phycotoxins, May 17-21, 2004, Wageningen Academic Publishers, Bethesda, Maryland, USA 2006, pp. 217-224.
45. Castegnaro, M., Maru, V, Petkova-Bocharova, T., Nikolov, I., Bartsch, H., Concentration of ochratoxin A in the urine of endemic nephropathy patients and controls in Bulgaria: Lack of detection of 4-hydroxyochratoxin A, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins. Endemic Nephropathy and Urinary Tract Tumours, IARC Sci. Publ. 1991, 115, 165-169.
46. Petkova-Bocharova, T., Castegnaro, M., Pfohl-Leszkowicz, A., Garren, L., et al., Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan Endemic Nephropathy: A one month follow up study, Facta Univ.: Ser. Med. Biol 2003, 10, 62-68.
47. Schwerdt, G., Freudinger, R., Silbernagl, S., Gekle, M., Ochratoxin A-binding proteins in rat organs and plasma and different cell lines of the kidney, Toxicology 1999, 135, 1-10.
48. Stojkovic, R., Hult, S., Gamulin, R., Plestina, R., High affinity binding of ochratoxin A to plasma constituents, Biochem. Int. 1984, 9, 33-38.
49. Pfohl-Leszkowicz, A., Molinié, A., Tozlovanu, M., Manderville, R. A., Combined toxic effects of ochratoxin A and citrinin, in vitro and in vivo, Proceeding of the ACS meeting 2007, September 2006, San Francisco, USA (in press).
50. Czerwiecki, L., Czajkowska, D., Witkowska-Gwiazdowska, A., On Ochratoxin A and fungal flora in Polish cereals from-conventional and ecological farms, Food Addit. Contam. 2002, 19, 470-477.
51. Jørgensen, K., Jacobsen, J. S., Occurence of ochratoxin A in Danish wheat and rye, 1992-1999, Food Addit. Contam. 2002, 19, 1184-1189.
52. Elmholt, S., Ecology of ochratoxin A producing Penicillium verrucosum, Occurence in field soil and grain with special attention to farming systme and on-farm frying practices, Biol. Agric. Horticult. 2003, 20, 311-337.
53. Pfohl-Leszkowicz, A., Grosse, Y., Castegnaro, M., Petkova-Bocharova, T., et al., Ochratoxin A related DNA adducts in urinary tract tumours of Bulgarian subjects, in: Phillips, D. H., Castegnaro, M., Barstch, H. (Eds.), Postlabeling Methods for Detection of DNA Adducts, IARC Sci. Publ. 1993, 124, 141-148.
54. Cosyns, J. P., Dehoux, J. P., Guiot, Y., Goebbels, R. M., et al., Chronic aristolochic acid toxicity in rabbits: A model of chinese herbs nephropathy? Kidney Int. 2001, 59, 2164-2173.
55. Zhang, X., Wu, H., Liao, P., Li, X., et al., NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats, Food Chem. Toxicol. 2006, 44, 1006-1014.
56. IARC Monograph on the evaluation of carcinogenic risks to human: Some traditional herbal medicines, some mycotoxins, Naphtalene and styrene, IARC Monographs 2002, 82, 68-128.